Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
25.46
-0.24 (-0.93%)
At close: Jul 8, 2026, 4:00 PM EDT
26.09
+0.63 (2.47%)
After-hours: Jul 8, 2026, 7:00 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $915.6 million as of July 8, 2026. Its market cap has increased by 1,315.10% in one year.
Market Cap
915.60M
Enterprise Value
675.05M
1-Year Change
1,315.10%
Ranking
Category
Stock Price
$25.46
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $915.60M, an increase of 73.18%. That is a compound annual growth rate of 25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 915.60M | 65.58% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 971.84M |
| Replimune Group | 966.21M |
| Geron | 955.87M |
| Design Therapeutics | 918.74M |
| Phathom Pharmaceuticals | 917.42M |
| Inventiva | 897.76M |
| Tenax Therapeutics | 887.97M |
| Theravance Biopharma | 881.60M |